Optical coherence tomography-guided stent optimization and clinical outcomes in all-comer patients with ST-elevation myocardial infarction
- 2 February 2026
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 27 (4) , 721-732
Abstract
Aims: Although the advantages of intra-coronary imaging guidance in percutaneous coronary intervention (PCI) have been reported, the advantage of optical coherence tomography (OCT) guided PCI has not been elucidated in patients with ST-elevation myocardial infarction (STEMI). This study assessed the association between OCT findings after stent implantation and 1-year outcomes in an all-comer STEMI population. Methods and results: The ATLAS-OCT trial was a prospective, multicentre, single-arm study enrolling STEMI patients within 24 h of symptom onset. OCT-guided PCI was preferred when feasible. This analysis included patients with analysable post-PCI OCT images. The primary endpoint was target vessel failure (TVF; all-cause death, target vessel myocardial infarction [TVMI], or target vessel revascularization [TVR]). OCT images were analysed independently, and outcomes assessed at 12 months. Of 632 patients, 439 (69.5%) underwent OCT-guided stenting with final analysable imaging. Mean minimal stent area (MSA) and stent expansion (SE) were 6.21 ± 2.27 mm² and 76.8 ± 15.6%, respectively. Optimization criteria (MSA > 4.5 mm² and/or SE > 70%) were met in 87.7%. Suboptimal expansion was associated with higher TVF (20.4% vs. 8.1%; HR 2.57, 95% CI: 1.29–5.11), driven by TVMI and TVR. Each 1 mm² MSA decrease and 10% SE reduction increased TVF odds by 23% and 33%, respectively. Minor OCT findings were not significantly associated with outcomes. Conclusion: In STEMI, suboptimal MSA and SE determined by OCT were associated with higher adverse event risk. These findings support OCT-guided PCI optimization to improve outcomes and warrant further evaluation in randomized trials. Study Registration: University Hospital Medical Information Network Clinical Trials Registry of Japan (UMIN-CTR number: 000048590)Keywords
Funding Information
- Abbott Medical Japan, LLC
This publication has 31 references indexed in Scilit:
- Feasibility of optical coherence tomography-guided primary percutaneous coronary intervention for STEMI: all-comer ATLAS-OCT trialCardiovascular Intervention and Therapeutics, 2025
- Optical Coherence Tomography–Guided Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Rationale and Design of the ATLAS-OCT StudyThe American Journal of Cardiology, 2023
- 10-Year Temporal Trends of In-Hospital Mortality and Emergency Percutaneous Coronary Intervention for Acute Myocardial InfarctionJACC: Asia, 2022
- Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent ImplantationJAMA, 2015
- Quantitative assessment of tissue prolapse on optical coherence tomography and its relation to underlying plaque morphologies and clinical outcome in patients with elective stent implantationInternational Journal of Cardiology, 2014
- Differential effects of post-dilation after stent deployment in patients presenting with and without acute myocardial infarctionAmerican Heart Journal, 2010
- Impact of Post-Intervention Minimal Stent Area on 9-Month Follow-Up Patency of Paclitaxel-Eluting StentsJACC: Cardiovascular Interventions, 2009
- Percutaneous coronary intervention–induced emboli during primary PCI for STEMI: Too little, too much, or too late?American Heart Journal, 2005
- Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantationJACC, 2005
- Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantationJACC, 2004